Mankind Pharma Ltd - Asset Resilience Ratio

Latest as of March 2026: 5.47%

Mankind Pharma Ltd (MANKIND) has an Asset Resilience Ratio of 5.47% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Mankind Pharma Ltd (MANKIND) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs15.37 Billion

≈ $166.25 Million USD Cash + Short-term Investments

Total Assets

Rs280.80 Billion

≈ $3.04 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2026)

This chart shows how Mankind Pharma Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see MANKIND total asset value.

Liquid Assets Composition Over Time

This chart breaks down Mankind Pharma Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read MANKIND total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs15.37 Billion	5.47%
Total Liquid Assets	Rs15.37 Billion	5.47%

Asset Resilience Insights

Limited Liquidity: Mankind Pharma Ltd maintains only 5.47% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Mankind Pharma Ltd Industry Peers by Asset Resilience Ratio

Compare Mankind Pharma Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	Drug Manufacturers - Specialty & Generic	1.18%
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	Drug Manufacturers - Specialty & Generic	0.01%

Annual Asset Resilience Ratio for Mankind Pharma Ltd (2019–2026)

The table below shows the annual Asset Resilience Ratio data for Mankind Pharma Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2026-03-31	5.47%	Rs15.37 Billion ≈ $166.25 Million	Rs280.80 Billion ≈ $3.04 Billion	-0.62pp
2025-03-31	6.09%	Rs16.91 Billion ≈ $182.86 Million	Rs277.60 Billion ≈ $3.00 Billion	-0.15pp
2024-03-31	6.24%	Rs7.46 Billion ≈ $80.72 Million	Rs119.63 Billion ≈ $1.29 Billion	-6.36pp
2023-03-31	12.60%	Rs12.24 Billion ≈ $132.35 Million	Rs97.15 Billion ≈ $1.05 Billion	+1.92pp
2022-03-31	10.68%	Rs9.77 Billion ≈ $105.63 Million	Rs91.48 Billion ≈ $989.29 Million	-18.15pp
2021-03-31	28.83%	Rs18.37 Billion ≈ $198.70 Million	Rs63.73 Billion ≈ $689.18 Million	+11.91pp
2020-03-31	16.92%	Rs8.58 Billion ≈ $92.82 Million	Rs50.73 Billion ≈ $548.66 Million	+16.32pp
2019-03-31	0.60%	Rs246.21 Million ≈ $2.66 Million	Rs41.12 Billion ≈ $444.74 Million	--

pp = percentage points

About Mankind Pharma Ltd

NSE:MANKIND India Drug Manufacturers - Specialty & Generic

Market Cap

$10.19 Billion

Rs941.95 Billion INR

Market Cap Rank

#2197 Global

#93 in India

Share Price

Rs2280.50

Change (1 day)

+0.02%

52-Week Range

Rs1927.40 - Rs2660.60

All Time High

Rs2998.40